Skip to main content
. 2008 Nov 25;27(1):76. doi: 10.1186/1756-9966-27-76

Figure 5.

Figure 5

Augmentation therapy modulates downstream effecters of Akt to apoptosis. The downstream effects of the Akt pathway were examined by Western blotting. Bad was phosphorylated by cisplatin (5 μmol/L) treatment, while LY294002 (10 μmol/L) inhibited the phosphorylation. Augmentation with LY294002 weakened Bad phosphorylation and increased the cleavage of caspases-3.

HHS Vulnerability Disclosure